Fundraising FoxChorda Pharma
Roanoke, US · Founded 2018 · Virginia corporation
Find your way into Chorda Pharma
Sign up to see every warm intro you have to Chorda Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chorda Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chorda Pharma develops a pipeline of opioid-free analgesics for managing chronic pain from conditions such as arthritis, diabetic neuropathy, and sports injuries. Its first product, Capsadyn, is an over-the-counter capsaicin-based topical cream for pain relief.
Founders & leadership
RC
Richard CarlissExecutive
RV
Robert VaughnNamed on SEC filing
TK
Troy KeyserNamed on SEC filing
Board
GR
George Robert Vaughan, Jr.Board director
AH
Aileen HelselBoard director
JB
John B Williamson IIIBoard director
Reported raises · per SEC filings
Form D private placements$492.5K disclosed across 2 rounds · 2021–2024
▶$200KraisedDec 2024 · 4 investors · PharmaceuticalsRule 506(b)
▶$200KraisedDec 2024 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- George Robert Vaughan, Jr.Director
- Aileen HelselDirector
- Richard CarlissExecutive Officer, Director, Promoter
- John B Williamson IIIDirector
- Victor IannelloExecutive Officer, Director, Promoter
- Offering amount
- $600K
- Amount sold
- $200K
- Minimum investment
- $1
- First sale
- Dec 2024
- Incorporated
- Corporation, Virginia
- Federal exemptions
- 06b
▶$292.5KraisedApr 2022 · 13 investors · PharmaceuticalsRule 506(b)
▶$292.5KraisedApr 2022 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Richard CarlissExecutive Officer, Director, Promoter
- Victor IannelloExecutive Officer, Director
- Robert VaughnDirector
- Troy KeyserDirector
- Offering amount
- $500K
- Amount sold
- $292.5K
- Minimum investment
- $5K
- First sale
- Dec 2021
- Incorporated
- Corporation, Virginia, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Chorda Pharma do?
- Chorda Pharma develops a pipeline of opioid-free analgesics for managing chronic pain from conditions such as arthritis, diabetic neuropathy, and sports injuries. Its first product, Capsadyn, is an over-the-counter capsaicin-based topical cream for pain relief.
- How much funding has Chorda Pharma raised?
- Chorda Pharma has disclosed $492.5K raised across 2 rounds.
- Where is Chorda Pharma headquartered?
- Chorda Pharma is headquartered in Roanoke, US.